Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between Hk$12 Mln & Hk$17 Mln For Six Months
Aug 21 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* SEES UNAUDITED NET PROFIT ATTRIBUTABLE OF BETWEEN HK$12
MILLION
AND HK$17 MILLION FOR SIX MONTHS
* EXPECTED DECREASE IN PROFIT DUE TO PRICE CUT OF CERTAIN
PRODUCTS
IN EXCHANGE FOR BEING INCLUDED IN NATIONAL REIMBURSEMENT SCHEME
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA